METHOD FOR REDUCING THE OCCURENCE OF INFECTION IN INFANTS Russian patent published in 2016 - IPC A23L33/00 A23L33/115 A23L33/21 

FIELD: medicine.

SUBSTANCE: composition contains (a) long chain polyunsaturated fatty acids (LC-PUFA) with 20 and 22 carbon atoms, wherein the amount of arachidonic acid (ARA) is less than 0.06 g per 100 g of fatty acids. Said acids include, per 100 g of fatty acids: 0.3-0.6 g of docosahexaenoic acid (DHA); 0.2-0.4 g of eicosapentaenoic Acid (EPA), wherein the weight ratio of ARA: DHA is less than 0.1, the weight ratio of ARA: EPA is less than 0.2. Composition contains one component selected from b1) or b2), b1) 1.5-2.5 g of non-digestible oligosaccharides per 100 kcal, including 1.4-2 g of galactooligosaccharides with DP of 2-7 and 0.1-0.5 g of fructopolysaccharides with DP of 2-150; or b2) 4-8 g of daily quantity of non-digestible oligosaccharides, including, calculated per day: 3.7-6.4 g of galactooligosaccharides with DP of 2-7 and 0.3-1.6 g of fructopolysaccharides with DP of 2-150. Invention relates to a packed liquid or powder composition for children aged 10-48 months, providing per 100 ml of the liquid composition or per 100 ml of powder composition diluted with water: (a) 15-25 mg of LC-PUFA with 20 and 22 carbon atoms, wherein the amount of ARA is less than 0.06 g per 100 g of fatty acids. Composition contains: (b) 1-1.5 g of non-digestible oligosaccharides per 100 ml and 1.5-2.5 g of non-digestible oligosaccharides per 100 kcal, which include 1.4-2 g per 100 kcal of galactooligosaccharides with DP of 2-7 and 0.1-0.5 g per 100 kcal of fructopolysaccharides with DP of 2-150 and average DP of 10-30; (c) 8-10 % of proteins, 35-45 % of fats and 45-55 % of carbohydrates. Invention relates to a packed liquid or powder composition for children aged 10-48 months providing a daily dosage of 60-130 mg, preferably 70-120 mg, more preferably 80-110 mg of LC-PUFA with 20 and 22 carbon atoms, wherein the amount of ARA is less than 0.06 g per 100 g of fatty acids. This composition comprises: (b) 4-8 g, preferably 5-7 g, of non-digestible oligosaccharides per day, including, calculated per day: 3.7-6.4 g, preferably 4.5-5.6 g of galactooligosaccharides with DP of 2-7; 0.3-1.6 g, preferably 0.5-1.4 g, of fructopolysaccharides with DP of 2-150, and average DP of 10-30; and, optionally, 8-10 % of proteins, 35-45 % of fats 45-55 % of carbohydrates. Said compositions include, per 100 g of fatty acids: 0.3-0.6 g of DHA; 0.2-0.4 g of EPA, wherein the weight ratio of ARA: DHA is less than 0.1, the weight ratio of ARA: EPA is less than 0.2.

EFFECT: disclosed is a composition for preparing a product for reducing the occurence of respiratory infection and/or intestine infection in infants, reducing the number of respiratory infectious diseases and/or intestine infectious diseases in infants and/or for treating and/or preventing respiratory infections and/or intestine infections in infants.

21 cl, 2 dwg, 3 tbl, 2 ex